新的血液测试PromarterEndo可以大大减少内分泌硬化的长时间诊断时间。 New blood test PromarkerEndo could drastically reduce the long diagnosis time for endometriosis.

蛋白质组学国际开发了一种新的血液测试,即PromarkerEndo,精确诊断内分泌硬化,有可能缩短平均七年的诊断期。 Proteomics International has developed a new blood test, PromarkerEndo, that accurately diagnoses endometriosis, potentially reducing the average seven-year diagnosis period. 这种非侵入性测试可以避免侵入性手术的需要,并有助于早点诊断病情,使全世界数百万妇女受益。 This non-invasive test could avoid the need for invasive surgeries and help diagnose the condition earlier, benefiting millions of women worldwide. 公司股票价格在宣布成功结果后上涨。 The company's share price rose after announcing the successful results.